In terms of CNAs, our analyses revealed a consistent trend in primary and metastatic samples of increased frequency of AURKA amplifications in patients with IBC versus patients with non-IBC (Fig. 1D and E, Supplementary Table 5 and Supplementary Table 6). The gene discussed is AURKA; the disease is inflammatory breast carcinoma.